# Single Dose Azithromycin to Prevent Cholera in Children

> **NCT04326478** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 920 (estimated)

## Conditions studied

- Cholera

## Interventions

- **DRUG:** Azithromycin
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04326478
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-31
- **Primary completion:** 2025-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 920 (ESTIMATED)
- **Last updated:** 2025-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04326478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04326478, "Single Dose Azithromycin to Prevent Cholera in Children". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04326478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*